Regulatory T-Cells (Tregs) Within Bone Marrow-Derived Stem Cells (BMSCs) Actively Confer Immunomodulatory and Neuroprotective Effects Against Stroke
Poster May 09, 2018
Elliot Neal, MS1; Sandra A. Acosta, MS PhD1; Yuji Kaneko, PhD1; Cesario V. Borlongan, MA PhD1
Stroke is the second leading cause of death worldwide and the third major cause of adult disability in adults. Regulatory T-cells (Tregs) may exert a neuroprotective effect on ischemic stroke by inhibiting both inflammation and effector T-cell activation. Transplantation of human bone marrow-derived stem cells (BMSCs) in ischemic stroke affords neuroprotection that results in part from the cells’ anti-inflammatory property. However, the relationship between Tregs and BMSCs in treatment of ischemic stroke has not been fully elucidated.
Immunocytochemistry (ICC) and flow cytometry were used to identify cells expressing phenotypic markers of Tregs: CD4, CD25, and FoxP3 protein. Tregs were isolated using magnetic sorting from murine spleens. Primary rat neuronal cells (PRNCs) were subjected to an oxygen-glucose deprivation and reperfusion (OGD/R) condition. The cells were re-perfused and co-cultured with Tregs and/or BMSCs. We measured neuronal cell viability using ICC with Hoechst and MAP2.
We detected a minority population of Tregs within BMSCs with both ICC and flow cytometry. PRNCs were protected from OGD/R when co-cultured with BMSCs containing varying proportions of Tregs. The BMSC treatment containing the native population of Tregs conferred maximal neuroprotection compared to the treatment conditions containing 0%, 10%, and 100% relative ratio Tregs. Increasing the Treg population resulted in increased IL-6 secretion and decreased FGF-beta secretion by BMSCs.
BMSC transplantation stands as a potent treatment for ischemic stroke. Modulation of the immune system is a key mechanism by which BMSCs confer neuroprotection. This study shows that a minority population of Tregs exists within the therapeutic BMSC population, and those Tregs are robust mediators of the immunomodulatory effect provided by BMSC transplantation. The ratio of Tregs found naturally in BMSCs correlates with the highest level of neuroprotection after ischemic stroke.
Characterization of a Type 2 diabetes-associated islet-specific enhancer cluster in STARD10 by genome editing of EndoC-βH1 cellsPoster
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
P450 Induction in Cryopreserved Hepatocytes from PXR and CAR Nuclear Receptor Knock-out RatsPoster
The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that regulate the expression of phase I (cytochrome P450s), phase II metabolizing enzymes and transporter genes in response to xenobiotics, including prescription drugs.READ MORE
Mass Spectrometry: From Imaging to Metabolic NetworksPoster
We show that network analysis of co-localized ions from mass spectrometry imaging data provides a detailed chemo-spatial insight into the metabolic heterogeneity of tumors. Furthermore, module preservation analysis between colorectal cancer patients with and without metastatic recurrence suggests hypotheses on the nature of the different local metabolic pathways.READ MORE